Severe infections occurring in the years leading up to a dementia diagnosis might accelerate underlying cognitive decline in these patients.
Overactive bladder was independently associated with increased odds of experiencing a recent fall among US adults aged 20 to 69 years.
On March 30, 2026, the FDA approved Ponlimsi, a biosimilar to Prolia, and is reviewing a biosimilar candidate for Xolair.
No significant associations were found between hormonal contraceptive use and idiopathic intracranial hypertension prevalence ...
Knee-specific combat trauma does not increase radiographic knee OA progression in the short term, but lower-limb loss is ...
On March 30, 2026, the FDA approved a high dose regimen for Spinraza (nusinersen) for the treatment of spinal muscular atrophy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results